Literature DB >> 16788737

Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia.

Le-Qin Cheng1, Myung Kyum Kim, Jun-Won Lee, Youn-Jin Lee, Deok-Chun Yang.   

Abstract

Ginsenoside Rb1 is the most predominant ginsenoside in Panax species (ginseng) and the hydrolysis of this ginsenoside produces pharmaceutically active compounds. Caulobacter leidyia GP45, one of the isolates having strong beta-glucosidase-producing activity, converted ginsenoside Rb(1) to the active metabolites by 91%. The structures of the resultant metabolites were identified by NMR. Ginsenoside Rb1 had been consecutively converted to ginsenoside Rd (1), F2(2) and compound K (3) via the hydrolyses of 20-C beta-(1-->6)-glucoside, 3-C beta-(1-->2)-glucoside, and 3-C beta-glucose of ginsenoside Rb1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16788737     DOI: 10.1007/s10529-006-9059-x

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  17 in total

1.  Co-transformation of Panax major ginsenosides Rb₁ and Rg₁ to minor ginsenosides C-K and F₁ by Cladosporium cladosporioides.

Authors:  Lunpeng Wu; Yan Jin; Chengri Yin; Longlv Bai
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-20       Impact factor: 3.346

2.  Identification of novel glycoside hydrolases via whole genome sequencing of Niabella ginsenosidivorans for production of various minor ginsenosides.

Authors:  Muhammad Zubair Siddiqi; Majid S Hashmi; Jung-Mi Oh; Sungkun Chun; Wan-Taek Im
Journal:  3 Biotech       Date:  2019-06-10       Impact factor: 2.406

Review 3.  Genome sequencing of strain Cellulosimicrobium sp. TH-20 with ginseng biotransformation ability.

Authors:  Fei Zheng; Wei Zhang; Xiaodan Chu; Yulin Dai; Jing Li; Huanxi Zhao; Liankui Wen; Hao Yue; Shanshan Yu
Journal:  3 Biotech       Date:  2017-07-11       Impact factor: 2.406

4.  Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.

Authors:  Tao Niu; Diane L Smith; Zhen Yang; Song Gao; Taijun Yin; Zhi-Hong Jiang; Ming You; Richard A Gibbs; Joseph F Petrosino; Ming Hu
Journal:  Pharm Res       Date:  2012-12-20       Impact factor: 4.200

5.  Microbial transformation of ginsenoside Rb1 to compound K by Lactobacillus paralimentarius.

Authors:  Lin-Hu Quan; Yeon-Ju Kim; Guan Hao Li; Kwang-Tea Choi; Deok-Chun Yang
Journal:  World J Microbiol Biotechnol       Date:  2013-01-22       Impact factor: 3.312

6.  Highly selective biotransformation of ginsenoside Rb1 to Rd by the phytopathogenic fungus Cladosporium fulvum (syn. Fulvia fulva).

Authors:  Xuesong Zhao; Juan Wang; Jie Li; Ling Fu; Juan Gao; Xiuli Du; Hongtao Bi; Yifa Zhou; Guihua Tai
Journal:  J Ind Microbiol Biotechnol       Date:  2009-02-20       Impact factor: 3.346

7.  Ginsenoside Rb1 alleviates colitis in mice via activation of endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 signaling pathway.

Authors:  Jian-Yi Dong; Kai-Jun Xia; Wei Liang; Lu-Lu Liu; Fang Yang; Xue-Sheng Fang; Yong-Jian Xiong; Liang Wang; Zi-Juan Zhou; Chang-Yi Li; Wei-Dong Zhang; Jing-Yu Wang; Da-Peng Chen
Journal:  Acta Pharmacol Sin       Date:  2020-12-02       Impact factor: 7.169

8.  Enzymatic Transformation of Ginsenoside Rb1 by Lactobacillus pentosus Strain 6105 from Kimchi.

Authors:  Se-Hwa Kim; Jin-Woo Min; Lin-Hu Quan; Sungyoung Lee; Dong-Uk Yang; Deok-Chun Yang
Journal:  J Ginseng Res       Date:  2012-07       Impact factor: 6.060

9.  Beneficial effects of american ginseng on epididymal sperm analyses in cyclophosphamide treated rats.

Authors:  Hosseini Akram; Firouz Ghaderi Pakdel; Abbas Ahmadi; Samad Zare
Journal:  Cell J       Date:  2012-08-31       Impact factor: 2.479

10.  Biotransformation of Ginsenoside Rb1 to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F2, and Compound K by Leuconostoc mesenteroides DC102.

Authors:  Lin-Hu Quan; Jin-Ying Piao; Jin-Woo Min; Ho-Bin Kim; Sang-Rae Kim; Dong-Uk Yang; Deok Chun Yang
Journal:  J Ginseng Res       Date:  2011-09       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.